Patterson Companies (PDCO) announced that its shareholders approved at a special meeting the acquisition of Patterson by Patient Square Capital. Under the terms of the Agreement and Plan of Merger dated December 10, 2024, in connection with the merger contemplated thereby, Patterson shareholders will receive $31.35 in cash per share of common stock. Patterson expects the transaction to close later this month, subject to the satisfaction of certain customary closing conditions set forth in the Merger Agreement. Upon completion of the transaction, Patterson will become a privately held company, and its common stock will no longer be traded on the NASDAQ Global Select Market.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PDCO:
- Hold Rating on Patterson Companies Amid Weaker Financials and Acquisition Distractions
- Utah fluoride ban could be marginal tailwind to dental demand, says BofA
- Patterson Companies Reports Q3 Fiscal 2025 Results
- Patterson Companies reports Q3 EPS 43c, consensus 62c
- PDCO Upcoming Earnings Report: What to Expect?
